Paul Hartmann (PHH2)
Paul Hartmann AG manufactures and sells medical and care products in Europe, Africa, Asia, and Oceania.
If you are interested in PHH2 stock information, you might also be interested in competitors like NYSE:CAH.
The market capitalization of Paul Hartmann is currently at 1.04€ B. This places it among the low capitalized companies.
The book value reported in the balance sheet results in a P/B ratio of 1.2.
With one share of Paul Hartmann investors achieved a dividend of 8.01€. This results in a good dividend yield of 2.39%. In the last 15 years, the annual dividend has risen constantly.
For the risk analysis, the low beta factor should be noted, which is currently at a value of 0.30. The price of the stock DB:PHH2 is therefore subject to moderate fluctuations in relation to the overall market.
Since not enough Wall Street analysts have published their estimates, we are unfortunately unable to provide a reliable price target for the PHH2 stock.
DB:PHH2 has a 52 week range of 328.00€ - 418.00€ and is currently trading around 335.00€.
The low short sale ratio indicated that the value might increase in the foreseeable future.